HomeGLMD • NASDAQ
add
Galmed Pharmaceuticals Ltd
Previous close
$1.49
Day range
$1.46 - $1.52
Year range
$1.15 - $23.80
Market cap
3.32M USD
Avg Volume
3.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.26M | -9.78% |
Net income | -1.10M | 13.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.24M | 10.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.73M | 45.49% |
Total assets | 18.68M | 28.67% |
Total liabilities | 1.81M | 2.38% |
Total equity | 16.88M | — |
Shares outstanding | 2.26M | — |
Price to book | 0.20 | — |
Return on assets | -17.00% | — |
Return on capital | -19.03% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.10M | 13.41% |
Cash from operations | -1.17M | 36.23% |
Cash from investing | -231.00K | -153.47% |
Cash from financing | 1.51M | — |
Net change in cash | 116.00K | 108.30% |
Free cash flow | -831.00K | 41.95% |
About
Founded
2000
Website
Employees
5
